Blog

Medical Device Industry Sign Historic Agreement to Reduce Health Fund Premiums

The Medical Technology Association of Australia (MTAA) has signed a four-year Agreement with the Federal Government which will deliver certainty and stability to the industry and will help lower Private Health Insurance (PHI) premiums for Australians. The Agreement,…

New US patent for Patrys PAT-LM1

Patrys (ASX:PAB), a clinical stage biotechnology company, has been granted a US patent for its anti-cancer pre-clinical candidate PAT-LM1. The US Patent Office has issued correspondence confirming the grant of a key patent in the PAT-LM1 family, patent…

Starpharma and Peter Mac Cancer Centre awarded DEP® Grant

Starpharma (ASX: SPL, OTCQX: SPHRY) and Peter MacCallum Cancer Centre (Peter Mac) have been awarded a further Federal Government Innovation Connections grant to support innovative research within Starpharma’s DEP® oncology program. Starpharma’s proprietary DEP® dendrimer platform improves efficacy…

LBT Receives $4.2 Million in R&D Incentives

Australian medical technology company LBT Innovations Limited (ASX:LBT) has received an R&D Incentive, net of income tax payable, of $3.98 Million for the financial year ended 30 June 2017. In addition, LBT has also received $0.22 Million for…

14th November – BioBriefing – The Changing Landscape for U.S. Venture Capital Investments in Healthcare

San Francisco-based Jon Baer is the Managing Partner at Threshold Ventures and will be visiting Melbourne as the final guest presenter for the 2017 Export Ready for North America Program. Jon will discuss the changing landscape for U.S. venture capital…

17th November – BioBriefing – Effective, Safe Medicines For All Ages: Innovation in Paediatric Drug Development

With International Guest Speaker: Dr Patrick Smith, Chief Scientific Officer, Consulting Services, Certara (US) and a panel of local experts  There are multiple challenges in paediatric drug development; children are not small adults and innovation in approaches to trials…

AdAlta appoints Dr Dallas Hartman as Chief Operating Officer

AdAlta Limited (ASX: 1AD), the biotechnology company advancing its lead i-body candidate towards clinical development, is pleased to announce the appointment of experienced executive, Dr Dallas Hartman to the role of Chief Operating Officer. Dr Hartman will bring…

BioMelbourne Network submission to the Policy Consultation Paper – Visa Simplification: Transforming Australia’s Visa System

“Australia’s visa system must remain globally competitive to attract talent to build future industries and transition to a knowledge-led economy” Health is a global market and access to global talent is critical for healthcare innovation. Companies need to…

GKC names John Schellhorn new President and CEO

GKC announced today that it has appointed John Schellhorn as its new President and CEO. Schellhorn will also be joining the company’s Board of Directors. Schellhorn joins GKC with a proven track record to spearhead the company’s accelerated…

Victoria’s new Boston office to help connect our world class med tech & pharma sector to key North American markets

The Andrews Labor Government today further expanded its international trade network with the opening of a new trade office in Boston. Minister for Small Business, Innovation and Trade Philp Dalidakis formally opened the new Victorian Government Trade and…

St Vincent’s Hospital Commences Global First APAS® In Situ Automated Evaluation

 Australian developed advanced pathology instrument reading and interpreting plates for faster diagnosis of infectious diseases  Centre of excellence laboratory to test automation efficiency in a busy real-life setting Adelaide, Australia, 27 September 2017: Australian medical technology…

U.S. Patent Granted for Cynata Cymerus™ Technology

Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX: CYP), is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has granted a patent covering aspects of Cynata’s proprietary Cymerus™ mesenchymal stem cell technology.…

Home

News & opinion

Member Directory

Events